Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Heemskerk, SCMRotteveel, AH
Benninga, MA
Baeten, CIM
Masclee, AAM
Melenhorst, J
van Kuijk, SMJ
Dirksen, CD
Breukink, SO
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysisPublished in
Int J Colorectal Dis 2018; 33(4):493-501Publiekssamenvatting
The evidence regarding the (cost-)effectiveness of sacral neuromodulation (SNM) in patients with therapy-resistant idiopathic slow-transit constipation is of suboptimal quality. The Dutch Ministry of Health, Welfare and Sports has granted conditional reimbursement for SNM treatment. The objective is to assess the effectiveness, cost-effectiveness, and budget impact of SNM compared to personalized conservative treatment (PCT) in patients with idiopathic slow-transit constipation refractory to conservative treatment.PMID
29470731ae974a485f413a2113503eed53cd6c53
10.1007/s00384-018-2978-x
Scopus Count
Collections
Related articles
- Sacral Neuromodulation Versus Conservative Treatment for Refractory Idiopathic Slow-transit Constipation: The Randomized Clinical No.2-Trial.
- Authors: Heemskerk SCM, Dirksen CD, van Kuijk SMJ, Benninga MA, Baeten CIM, Masclee AAM, Melenhorst J, Breukink SO
- Issue date: 2023 Nov 23
- Cost-effectiveness of sacral neuromodulation for chronic refractory constipation in children and adolescents: a Markov model analysis.
- Authors: van der Wilt AA, Groenewoud HHM, Benninga MA, Dirksen CD, Baeten CGMI, Bouvy ND, Melenhorst J, Breukink SO
- Issue date: 2017 Nov
- Long-term outcome of intractable constipation treated by sacral neuromodulation: a comparison between children and adults.
- Authors: Janssen PTJ, Meyer YM, Van Kuijk SMJ, Benninga MA, Stassen LPS, Bouvy ND, Melenhorst J, Breukink SO
- Issue date: 2018 Feb
- Sacral nerve stimulation for intractable constipation.
- Authors: Kamm MA, Dudding TC, Melenhorst J, Jarrett M, Wang Z, Buntzen S, Johansson C, Laurberg S, Rosen H, Vaizey CJ, Matzel K, Baeten C
- Issue date: 2010 Mar
- Sacral neuromodulation therapy: a promising treatment for adolescents with refractory functional constipation.
- Authors: van Wunnik BP, Peeters B, Govaert B, Nieman FH, Benninga MA, Baeten CG
- Issue date: 2012 Mar